Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Single- and Multiple-Dose Milnacipran Pharmacokinetics in Healthy Han Chinese Volunteers

Published:2015-12-10 Issue:7 Volume:55 Page:889-896
ISSN:0312-5963
Container-title:Clinical Pharmacokinetics
language:en
Short-container-title:Clin Pharmacokinet

Author:

Ruan Can-Jun,Li An-Ning,Dong Fang,Zhai Yi-Min,Li Wen-Biao,Wang Chuan-Yue,de Leon Jose

Funder

Shanghai Shyndec Pharmaceutical Co., Ltd

the Beijing municipal administration of hospitals clinical medicine development of special funding

Capital Medical Research Development Fund of China

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s40262-015-0355-2.pdf

Reference21 articles.

1. Assie MB, Charveron M, Palmier C, Puozzo C, Moret C, Briley M. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat. Neuropharmacology. 1992;31(2):149–55.

2. Kasper S, Pail G. Milnacipran: a unique antidepressant? Neuropsychiatr Dis Treat. 2010;6(Suppl 1):23–31.

3. Saraceni MM, Venci JV, Gandhi MA. Levomilnacipran (Fetzima): a new serotonin-norepinephrine reuptake inhibitor for the treatment of major depressive disorder. J Pharm Pract. 2013;27(4):389–95.

4. Citrome L. Levomilnacipran for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant—what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract. 2013;67(11):1089–104.

5. Preskorn SH. Milnacipran: a dual norepinephrine and serotonin reuptake pump inhibitor. J Psychiatr Pract. 2004;10(2):119–26.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants;The World Journal of Biological Psychiatry;2021-05-12

2. First-in-human safety, tolerability, and pharmacokinetics of ammoxetine in healthy subjects: a randomized, double-blind, placebo-controlled phase I study;European Journal of Pharmaceutical Sciences;2021-04

3. New-Generation, Non-SSRI Antidepressants: Therapeutic Drug Monitoring and Pharmacological Interactions. Part 1: SNRIs, SMSs, SARIs;Current Medicinal Chemistry;2018-03-15

4. Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017;Pharmacopsychiatry;2017-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3